Skip to main content

Find Clinical Trials

Home
Conditions
Doxorubicin

Clinical trial condition

Doxorubicin

Explore clinical trials studying Doxorubicin. Study availability and eligibility vary by location and protocol.

6 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Doxorubicin trial results

Recruiting

Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2)

NCT06960577

Conditions: Cisplatin, Doxorubicin, Female Urogenital Diseases, +14 more
Locations: Research Site Chermside, Australia

Research Site Elizabeth Vale, Australia

Research Site Heidelberg, Australia

Research Site Hong Kong, Australia

View all 59 locations

View Trial Details

Recruiting

Anlotinib Combined With Doxorubicin and Radiotherapy as Neoadjuvant Treatment for Soft Tissue Sarcoma

NCT06506838

Conditions: Doxorubicin, Neoplasms, Neoplasms by Histologic Type, +4 more
Locations: Guangdong Provincial People's Hospital Guangzhou, Guangdong, China

Guangdong provincial people's hospital Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

Cardioprotective Effect of Melatonin Versus Vitamin D in Breast Cancer Patients Receiving Doxorubicin

NCT07349459

Conditions: Breast Cancer Patients Diagnosed, Doxorubicin, Melatonin, +1 more
Locations: Tanta University Tanta, Egypt

View Trial Details

Completed

Anti-CD30 (Brentuximab Vedotin) With AVD Versus ABVD Chemotherapy Protocol Frontline Therapy in Patients With Advanced Classical Hodgkin Lymphoma

NCT07171827

Conditions: Advanced Classical Hodgkin Lymphoma, Anti-CD30, Brentuximab, +4 more
Locations: Helwan University Helwan, Egypt

View Trial Details

Completed

Effect of Pentoxifylline on Preventing Chemotherapy-induced Toxicities in Patients With Breast Cancer

NCT06186700

Conditions: Breast Cancer Female, Breast Cancer Patients, Digestive System Diseases, +8 more
Locations: Oncology Center of Mansoura University Al Mansurah, Egypt

View Trial Details

Completed

Phase III Comparison of Adjuvant Chemotherapy W/High-Dose Cyclophosphamide Plus Doxorubicin (AC) vs Sequential Doxorubicin Fol by Cyclophosphamide (A-C) in High Risk Breast Cancer Patients With 0-3 Positive Nodes (Intergroup, CALGB 9394)

NCT00590785

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details